Single-cell quantification of IL-2 response by effector and regulatory T cells reveals critical plasticity in immune response
暂无分享,去创建一个
Michael W. Sneddon | G. Altan-Bonnet | Kendall A. Smith | O. Feinerman | G. Jentsch | Karen E. Tkach | Jesse Coward | Matthew M Hathorn | T. Emonet | Garrit Jentsch | Kendall A. Smith
[1] J. Economou,et al. Lymphocyte-activating factor. I. Generation and physicochemical characterization. , 1978, Journal of immunology.
[2] H. Berg. Random Walks in Biology , 2018 .
[3] D. Cantrell,et al. The interleukin-2 T-cell system: a new cell growth model. , 1984, Science.
[4] D. Cantrell,et al. Interleukin 2 regulates its own receptors. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[5] A. Dautry‐Varsat,et al. Receptor-mediated endocytosis of interleukin 2 in a human tumor T cell line. Degradation of interleukin 2 and evidence for the absence of recycling of interleukin receptors. , 1986, The Journal of biological chemistry.
[6] P. Néve,et al. Interleukin 2 , 1987, Acta clinica Belgica.
[7] Kendall A. Smith,et al. The interleukin 2 receptor. Functional consequences of its bimolecular structure , 1987, The Journal of experimental medicine.
[8] Kendall A. Smith,et al. Interleukin-2: inception, impact, and implications. , 1988, Science.
[9] A. Dautry‐Varsat,et al. Down-regulation of high affinity interleukin 2 receptors in a human tumor T cell line. Interleukin 2 increases the rate of surface receptor decay. , 1988, The Journal of biological chemistry.
[10] M. Ferrer,et al. Modulation of interleukin 2 internalization and interleukin 2-dependent cell growth by antireceptor antibodies. , 1991, The Journal of biological chemistry.
[11] M. Lenardo. lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis , 1991, Nature.
[12] M. Lenardo. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. , 1991, Nature.
[13] I. Horak,et al. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting , 1991, Nature.
[14] T. Waldmann,et al. The interleukin-2 receptor. , 1991, The Journal of biological chemistry.
[15] W. Paul,et al. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice , 1992, The Journal of experimental medicine.
[16] N. Tanaka,et al. Cloning of the gamma chain of the human IL-2 receptor. , 1992, Science.
[17] D A Lauffenburger,et al. The role of low-affinity interleukin-2 receptors in autocrine ligand binding: alternative mechanisms for enhanced binding effect. , 1994, Molecular immunology.
[18] H. Griesser,et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. , 1995, Science.
[19] M. Toda,et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.
[20] E Morelon,et al. Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains , 1995, The Journal of cell biology.
[21] F. Alt,et al. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. , 1995, Immunity.
[22] Kendall A. Smith,et al. Interleukin‐2 Deficient Mice: A New Model to Study Autoimmunity and Self‐Tolerance , 1995, Immunological reviews.
[23] B. Goldstein,et al. Solution Assembly of a Soluble, Heteromeric, High Affinity Interleukin-2 Receptor Complex (*) , 1995, The Journal of Biological Chemistry.
[24] C. Janeway,et al. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[25] Ethan M. Shevach,et al. CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production , 1998, The Journal of experimental medicine.
[26] Z Reich,et al. Ligand recognition by alpha beta T cell receptors. , 1998, Annual review of immunology.
[27] M. Surette,et al. Quorum sensing in Escherichia coli, Salmonella typhimurium, and Vibrio harveyi: a new family of genes responsible for autoinducer production. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[28] B. Goldstein,et al. Solution assembly of the pseudo‐high affinity and intermediate affinity interleukin‐2 receptor complexes , 2008, Protein science : a publication of the Protein Society.
[29] W. Leonard,et al. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines , 2000, Oncogene.
[30] J. Ihle. The Stat family in cytokine signaling. , 2001, Current opinion in cell biology.
[31] C. Surh,et al. Autologous Regulation of Naive T Cell Homeostasis Within the T Cell Compartment1 , 2001, The Journal of Immunology.
[32] W. Leonard,et al. The Basis for IL-2-Induced IL-2 Receptor α Chain Gene Regulation , 2001 .
[33] W. Leonard,et al. The basis for IL-2-induced IL-2 receptor alpha chain gene regulation: importance of two widely separated IL-2 response elements. , 2001, Immunity.
[34] Y. Belkaid,et al. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.
[35] Mark M. Davis,et al. Direct observation of ligand recognition by T cells , 2002, Nature.
[36] Byron Goldstein,et al. Analysis of the role of the interleukin-2 receptor gamma chain in ligand binding. , 2002, Biochemistry.
[37] J. Ellery,et al. Alternate signalling pathways from the interleukin-2 receptor. , 2002, Cytokine & growth factor reviews.
[38] A. Norment,et al. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell‐mediated suppression in vitro , 2003, European journal of immunology.
[39] Ruslan Medzhitov,et al. Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells , 2003, Science.
[40] Mark M Davis,et al. Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. , 2003, Molecular cell.
[41] Stanislav Y Shvartsman,et al. Stochastic model of autocrine and paracrine signals in cell culture assays. , 2003, Biophysical journal.
[42] Ronald H. Schwartz,et al. IL-2 Secretion by CD4+ T Cells In Vivo Is Rapid, Transient, and Influenced by TCR-Specific Competition , 2004, The Journal of Immunology.
[43] S. Sakaguchi. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.
[44] S. Rutz,et al. Interleukin‐2 is essential for CD4+CD25+ regulatory T cell function , 2004, European journal of immunology.
[45] William S. Hlavacek,et al. BioNetGen: software for rule-based modeling of signal transduction based on the interactions of molecular domains , 2004, Bioinform..
[46] S. Shvartsman,et al. Ligand trapping in epithelial layers and cell cultures. , 2004, Biophysical chemistry.
[47] Adrian Vella,et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. , 2005, American journal of human genetics.
[48] M. Veldhoen,et al. CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production. , 2005, International immunology.
[49] Ronald N Germain,et al. Modeling T Cell Antigen Discrimination Based on Feedback Control of Digital ERK Responses , 2005, PLoS biology.
[50] K. Christopher Garcia,et al. The Structure of Interleukin-2 Complexed with Its Alpha Receptor , 2005, Science.
[51] Angela Hughson,et al. Early Kinetic Window of Target T Cell Susceptibility to CD25+ Regulatory T Cell Activity1 , 2005, The Journal of Immunology.
[52] D. Gray,et al. CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[53] K. Garcia,et al. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. , 2005, Science.
[54] H. Boehmer,et al. Mechanisms of suppression by suppressor T cells , 2005, Nature Immunology.
[55] Garry P. Nolan,et al. Coordinate Analysis of Murine Immune Cell Surface Markers and Intracellular Phosphoproteins by Flow Cytometry1 , 2005, The Journal of Immunology.
[56] N. Burroughs,et al. Regulatory T cell adjustment of quorum growth thresholds and the control of local immune responses. , 2006, Journal of theoretical biology.
[57] A. Adler,et al. Cutting Edge: Paracrine, but Not Autocrine, IL-2 Signaling Is Sustained during Early Antiviral CD4 T Cell Response1 , 2006, The Journal of Immunology.
[58] E. Shevach,et al. The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells , 2006, Immunological reviews.
[59] Jean Imbert,et al. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. , 2006, Cytokine & growth factor reviews.
[60] C. Tomlin,et al. Biology by numbers: mathematical modelling in developmental biology , 2007, Nature Reviews Genetics.
[61] J. Rogers,et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity , 2007, Nature Genetics.
[62] Cristina M. Tato,et al. Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals , 2007, The Journal of experimental medicine.
[63] Melissa L. Kemp,et al. Quantitative Network Signal Combinations Downstream of TCR Activation Can Predict IL-2 Production Response1 , 2007, The Journal of Immunology.
[64] J. Todd,et al. Association of the interleukin‐2 receptor alpha (IL‐2Rα)/CD25 gene region with Graves’ disease using a multilocus test and tag SNPs , 2007, Clinical endocrinology.
[65] S. Ishihara,et al. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation–mediated apoptosis of effector CD4+ T cells , 2007, Nature Immunology.
[66] J. Bluestone,et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. , 2008, Immunity.
[67] A. Rudensky,et al. Coordination of Early Protective Immunity to Viral Infection by Regulatory T Cells , 2008, Science.
[68] R. Germain,et al. Variability and Robustness in T Cell Activation from Regulated Heterogeneity in Protein Levels , 2008, Science.
[69] A. Scheffold,et al. IL‐2 induces in vivo suppression by CD4+CD25+Foxp3+ regulatory T cells , 2008, European journal of immunology.
[70] J. Sprent,et al. In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression , 2009, The Journal of experimental medicine.
[71] S. Sakaguchi,et al. Regulatory T cells: how do they suppress immune responses? , 2009, International immunology.
[72] Andreas Radbruch,et al. Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12. , 2009, Immunity.
[73] S. Holland,et al. Analysis of Adhesion Molecules, Target Cells, and Role of IL-2 in Human FOXP3+ Regulatory T Cell Suppressor Function1 , 2009, The Journal of Immunology.
[74] E. Shevach. Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.
[75] Peter O. Krutzik,et al. The Initial Phase of an Immune Response Functions to Activate Regulatory T Cells1 , 2009, The Journal of Immunology.
[76] Dorothea Busse,et al. Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments , 2010, Proceedings of the National Academy of Sciences.
[77] J. Thèze,et al. IL-2 induces conformational changes in its preassembled receptor core, which then migrates in lipid raft and binds to the cytoskeleton meshwork. , 2010, Journal of molecular biology.
[78] The Initial Phase , 2011 .
[79] Stephen T. C. Wong,et al. Coordination of Early Protective Immunity to Viral Infection by Regulatory T Cells , 2022 .